Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

CDC-Authored Genomics and Precision Health Publications Database|Home|PHGKB

CDC-Authored Genomics and Precision Health Publications Database


Last data update: Jun 02, 2023. (Total: 4301 publications since 2011)
   dataset
Filtered By:
Records 1-10 (of 10 Records)
Query Trace: all>>Tamara Pilishvili[CDC Author]
SARS-CoV-2 infection history and antibody response to three COVID-19 mRNA vaccine doses.
Herring MK , Romine JK , Wesley MG , Ellingson KD , Yoon SK , Caban-Martinez AJ , Meece J , Gaglani M , Grant L , Olsho LEW , Tyner HL , Naleway AL , Khan SM , Phillips AL , Solle NS , Rose S , Mak J , Fuller SB , Hunt A , Kuntz JL , Beitel S , Yoo YM , Zheng PQ , Arani G , Lamberte JM , Edwards T , Thompson MG , Sprissler R , Thornburg NJ , Lowe AA , Pilishvili T , Uhrlaub JL , Lutrick K , Burgess JL , Fowlkes AL .
Clin Infect Dis 2023 76 (10) 1822-1831 type
Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization.
Feikin DR , Higdon MM , Andrews N , Collie S , DeloriaKnoll M , Kwong JC , Link-Gelles R , Pilishvili T , Patel MK .
Vaccine 2023 type
Effectiveness of a Second COVID-19 Vaccine Booster Dose Against Infection, Hospitalization, or Death Among Nursing Home Residents - 19 States, March 29-July 25, 2022.
McConeghy KW , White EM , Blackman C , Santostefano CM , Lee Y , Rudolph JL , Canaday D , Zullo AR , Jernigan JA , Pilishvili T , Mor V , Gravenstein S .
MMWR Morb Mortal Wkly Rep 2022 71 (39) 1235-1238 type
Effectiveness of COVID-19 vaccination against SARS-CoV-2 Infection among Residents of US Nursing Homes, Before and During the Delta variant Predominance, December 2020 - November 2021.
Hatfield KM , Baggs J , Wolford H , Fang M , Sattar AA , Montgomery KS , Jin S , Jernigan J , Pilishvili T .
Clin Infect Dis 2022 75 S147-S154 type
Cost-effectiveness of implementing 13-valent pneumococcal conjugate vaccine for U.S. adults aged 19 years and older with underlying conditions.
Kobayashi M , Stoecker C , Xing W , Cho BH , Pilishvili T .
Hum Vaccin Immunother 2021 17 (7) 1-9
Invasive pneumococcal strain distributions and isolate clusters associated with persons experiencing homelessness during 2018.
Metcalf BJ , Chochua S , Walker H , Tran T , Li Z , Varghese J , SnippesVagnone PM , Lynfield R , McGee L , Li Y , Pilishvili T , Beall B .
Clin Infect Dis 2020 72 (12) e948-e956
Multistate population and whole genome sequence based strain surveillance of invasive pneumococci recovered in the United States during 2017.
Varghese J , Chochua S , Tran T , Walker H , Li Z , SnippesVagnone PM , Lynfield R , McGee L , Li Y , Metcalf B , Pilishvili T , Beall B .
Clin Microbiol Infect 2019 26 (4) 512 e1-512 e10
Genome-wide association analyses of invasive pneumococcal isolates identify a missense bacterial mutation associated with meningitis.
Li Y , Metcalf BJ , Chochua S , Li Z , Walker H , Tran T , Hawkins PA , Gierke R , Pilishvili T , McGee L , Beall BW .
Nat Commun 2019 10 (1) 178
A Population-Based Descriptive Atlas of Invasive Pneumococcal Strains Recovered Within the U.S. During 2015-2016.
Beall B , Chochua S , Gertz RE Jr , Li Y , Li Z , McGee L , Metcalf BJ , Ricaldi J , Tran T , Walker H , Pilishvili T .
Front Microbiol 2018 9 2670
Post-licensure surveillance of 13-valent pneumococcal conjugate vaccine (PCV13) in adults aged ⩾19years old in the United States, Vaccine Adverse Event Reporting System (VAERS), June 1, 2012-December 31, 2015.
Haber Penina, Arana Jorge, Pilishvili Tamara, Lewis Paige, Moro Pedro L, Cano Maria. Vaccine 2016 34(50) 6330-6334 .
Vaccine 2016 34(50) 6330-6334
TOP